Skip to content
RG+A Customer Creed
Our Core Values
Kevin M. Kelly
Tim Deckman, Ph.D.
Ellen J. Gordon, Ph.D.
Bruce Duncan, Ph.D.
Joan L. Lorgus
Treatment Areas and Therapeutic Drug Classes
Forecasting Physician Treatment Decisions across Multiple Lines of Therapy
Better Answers with Imprecise Data
Attribute Importance Ratings: Are We Learning Anything We Don’t Already Know?
Product Positioning for an Innovative In-Home Medical Device
Hazardous Drug Detection for Employee Safety
Assessing Market Potential and Development Strategy
Pricing and Volumetric Forecasting for an Orphan Drug
Using DPS®/Conjoint to Formulate a Competitive Response
Forecasting for Multiple Indications within the ADHD Market
Generic Competition Assessment Among Payers Using PV Scope®
Using Co-Creation with Payers to Support Optimal Product Profile Development and Clinical Trial Design
Applying Dynamic Practice Simulation (DPS) to Development and Commercialization Strategy
Developing Competitive Contracting Strategies using Contract Simulation®
Contracting Strategy Development using Qualitative Conjoint to Segment Community Oncology Practice Managers
Forecasting and Strategy Development for a Neurological Product
Feature Optimization via Qualitative Conjoint to Combat Competitive Threat in the Vascular Device Space
Areas of Expertise
Strategic Risk Modeling
Product Development & Positioning
Business Development and Licensing
Orphan and Ultra-Orphan Tools
Health Payer Council® (HPC®)
Dynamic Practice Simulation® (DPS®)
Dynamic Practice Simulation® Line of Therapy
Health Payer Insights (HPI)
Wisdom of Crowds
Health Payer Council® News
Join our Mailing List
It seems we can’t find what you’re looking for. Perhaps searching can help.